295 related articles for article (PubMed ID: 25708106)
1. Gene therapy for primary immunodeficiencies.
Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
3. Strategies for retrovirus-based correction of severe, combined immunodeficiency (SCID).
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Methods Enzymol; 2012; 507():15-27. PubMed ID: 22365767
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for inherited immunodeficiency.
Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
[TBL] [Abstract][Full Text] [Related]
5. [Safety of retroviral vectors in gene therapy].
Bogoslovskaia EV; Glazkova DV; Shipulin GA; Pokrovskiĭ VV
Vestn Ross Akad Med Nauk; 2012; (10):55-61. PubMed ID: 23240501
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for severe combined immunodeficiencies and beyond.
Fischer A; Hacein-Bey-Abina S
J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
[TBL] [Abstract][Full Text] [Related]
8. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for severe combined immunodeficiencies.
Gaspar HB; Thrasher AJ
Expert Opin Biol Ther; 2005 Sep; 5(9):1175-82. PubMed ID: 16120048
[TBL] [Abstract][Full Text] [Related]
10. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of inherited immunodeficiencies.
Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Le Deist F; Soudais C; Di Santo JP; de Saint Basile G; Cavazzana-Calvo M
Immunol Rev; 2000 Dec; 178():13-20. PubMed ID: 11213798
[TBL] [Abstract][Full Text] [Related]
14. Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.
Cassani B; Montini E; Maruggi G; Ambrosi A; Mirolo M; Selleri S; Biral E; Frugnoli I; Hernandez-Trujillo V; Di Serio C; Roncarolo MG; Naldini L; Mavilio F; Aiuti A
Blood; 2009 Oct; 114(17):3546-56. PubMed ID: 19652199
[TBL] [Abstract][Full Text] [Related]
15. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapies for Primary Immune Deficiencies.
Kohn LA; Kohn DB
Front Immunol; 2021; 12():648951. PubMed ID: 33717203
[TBL] [Abstract][Full Text] [Related]
17. Parachuting in the epigenome: the biology of gene vector insertion profiles in the context of clinical trials.
Baum C
EMBO Mol Med; 2011 Feb; 3(2):75-7. PubMed ID: 21254403
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for primary immunodeficiencies: Part 2.
Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for adenosine deaminase deficiency.
Cappelli B; Aiuti A
Immunol Allergy Clin North Am; 2010 May; 30(2):249-60. PubMed ID: 20493400
[TBL] [Abstract][Full Text] [Related]
20. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]